feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Science / Home Alzheimer's Test: Finger Prick Breakthrough?

Home Alzheimer's Test: Finger Prick Breakthrough?

19 Jan

•

Summary

  • A new finger-prick blood test aims to detect Alzheimer's risk.
  • Trial involves 1,000 volunteers, with results expected in 2028.
  • This test could allow for home-based screening without refrigeration.
Home Alzheimer's Test: Finger Prick Breakthrough?

A novel finger-prick blood test is currently undergoing trials, offering a potential breakthrough in early Alzheimer's detection. Scientists are analyzing results from 1,000 volunteers to determine the test's efficacy in identifying abnormal amyloid protein, a key indicator of Alzheimer's risk. Dr. Emer MacSweeney highlights its potential for a ubiquitous, accurate, and less complicated diagnostic tool.

The ongoing study seeks to understand if blood tests can improve diagnosis and treatment in real-world scenarios, with a US regulator having already approved a needle-and-syringe blood test for Alzheimer's diagnosis last year. A significant advantage of this finger-prick method is its suitability for home use, as samples do not require refrigeration and can be mailed to a lab.

The trial, which includes participants with varying cognitive statuses, aims to complete by 2028, with at least 25% of volunteers from under-represented groups. Hopes are high that such blood tests could eventually serve as a crucial screening tool for dementia in older adults, making early detection more accessible.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Dr. Emer MacSweeney is involved with a finger-prick blood test trial aimed at detecting Alzheimer's risk.
The trial is expected to complete in 2028, with results analyzed thereafter.
Yes, a key advantage of the finger-prick test is its potential for home use, with samples mailed to a lab.

Read more news on

Scienceside-arrow
trending

Chelsea beats West Ham 3-2

trending

Liverpool, Newcastle face injury woes

trending

WWE Royal Rumble in Riyadh

trending

Barcelona faces Elche in LaLiga

trending

Goretzka staying at Bayern Munich

trending

ICC T20 World Cup squads

trending

Gold, silver ETFs crashed

trending

Curran, Pandya T20Is stats compared

trending

Suryakumar Yadav T20I record

You may also like

Women's Alzheimer's Risk: The Unseen Gender Gap

1 day ago • 9 reads

article image

MIND Diet Slashes Alzheimer's Risk by 53%

1 day ago • 7 reads

article image

Subtle Driving Shifts Hint at Dementia Risk

29 Jan • 14 reads

Blood Sugar Spikes Linked to Alzheimer's Risk

16 Jan • 104 reads

article image

Vaccines May Slash Dementia Risk, Study Shows

7 Jan • 179 reads

article image